週边血管支架市场规模、份额和成长分析（按产品类型、材质类型、最终用户、疾病类型和地区划分）—2026-2033年产业预测

预计到 2024 年，全球週边支架市场规模将达到 48 亿美元，到 2025 年将达到 51.6 亿美元，到 2033 年将达到 92 亿美元，预测期（2026-2033 年）的复合年增长率为 7.5%。

心血管疾病发生率的不断上升预计将成为週边支架市场扩张的主要驱动因素。此外，糖尿病和高血压併发症也可能增加对这些支架的需求。全球人口老化为该领域的製造商带来了可观的前景。此外，微创手术的日益普及预计将为週边支架供应商创造新的机会。然而，潜在的手术併发症、来自替代疗法的竞争以及熟练的血管通路专家的短缺等挑战可能会阻碍市场成长。此外，不良的生活方式和饮食习惯也持续间接影响週边支架市场的前景。

全球週边血管支架市场驱动因素

居家医疗和门诊治疗的日益普及显着推动了周边支架的需求。这些支架对于接受抗生素、免疫疗法、营养支持和慢性病治疗等疗法的患者有效输送药物至关重要。随着全球范围内对以患者为中心的医疗保健的日益重视，预计这将对外周支架市场产生积极影响。这种朝向更便利、更容易取得的医疗保健方式的转变，推动了对支架等先进医疗解决方案的需求，最终促进了其销售，并使其在医疗保健生态系统中得到更广泛的应用。

限制全球週边血管支架市场的因素

全球週边支架市场的销售潜力可能受到支架正确植入相关挑战的限制，因为正确植入需要专门的训练。许多医疗机构缺乏合格的护士、血管通路专家和训练有素的临床医生来执行这些操作。此外，人员离职率率高和标准化认证项目有限也使情况更加复杂。这些因素综合起来，可能会阻碍週边支架的广泛应用，限制其在各种医疗机构中的可用性和使用，从而影响市场成长。

全球週边血管支架市场趋势

全球週边支架市场正经历着向家庭输液治疗和长期门诊护理设备的转型。供应商不断创新，致力于研发更耐用、感染风险更低、维护更便利的支架，使其能够在传统医院环境之外使用。这一趋势与旨在降低医疗成本和缓解医院拥堵的居家照护解决方案需求不断增长相吻合。随着患者和医疗服务提供者寻求更便捷高效的治疗方案，对专为居家照护设计的高级外周支架的需求持续增长，标誌着市场格局的重要演变。

目录

介绍

• 调查目标
• 市场定义和范围

调查方法

• 调查过程
• 二手资料和一手资料方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争格局概述

市场动态与展望

• 总体经济指标
• 驱动因素和机会
• 限制与挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

关键市场考察

• 关键成功因素
• 影响市场的因素
• 关键投资机会
• 生态系测绘
• 市场吸引力指数（2025）
• PESTEL 分析
• 价值链分析
• 定价分析
• 案例研究
• 监管环境
• 技术评估
• 专利分析

全球週边血管支架市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 裸金属支架
• 药物释放型支架
• 生物可吸收支架

全球週边血管支架市场规模（按材料类型和复合年增长率划分）（2026-2033 年）

• 不銹钢
• 钴铬合金
• 聚合物基

全球週边血管支架市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 门诊手术中心
• 专科诊所

全球週边血管支架市场规模（按疾病类型和复合年增长率划分）（2026-2033 年）

• 周边动脉疾病
• 冠状动脉疾病
• 其他血管疾病

全球週边血管支架市场规模及复合年增长率（2026-2033）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Boston Scientific
• Medtronic
• Abbott
• Cook Medical
• Terumo Corporation
• St Jude Medical
• B. Braun Melsungen
• AngioDynamics
• Cardiovascular Systems, Inc.
• Vascular Solutions
• Gore & Associates
• Olympus Corporation
• Merit Medical Systems
• iVascular
• Endologix
• Spectranetics
• Medglad
• Getinge Group
• Biotronik
• Avinger

结论与建议

Global Peripheral Vascular Stents Market size was valued at USD 4.8 Billion in 2024 and is poised to grow from USD 5.16 Billion in 2025 to USD 9.2 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

The growing incidence of cardiovascular diseases is expected to be a major catalyst for the expansion of the peripheral vascular stents market. Additionally, complications arising from diabetes and hypertension will likely enhance the demand for these stents. The increasing elderly population globally presents promising prospects for manufacturers in this sector. Furthermore, the rising trend toward minimally invasive surgical procedures is anticipated to create new opportunities for peripheral vascular stent providers. However, challenges such as potential complications from procedures, competition from alternative therapies, and a lack of skilled vascular access professionals may hinder market growth. Moreover, lifestyle choices and poor dietary habits continue to indirectly influence the outlook for the peripheral vascular stents market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peripheral Vascular Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Peripheral Vascular Stents Market Segments Analysis

Global Peripheral Vascular Stents Market is segmented by Product Type, Material Type, End User, Disease Type and region. Based on Product Type, the market is segmented into Bare Metal Stents, Drug-Eluting Stents and Bioresorbable Stents. Based on Material Type, the market is segmented into Stainless Steel, Cobalt-Chromium Alloy and Polymer-based. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers and Specialized Clinics. Based on Disease Type, the market is segmented into Peripheral Artery Disease, Coronary Artery Disease and Other Vascular Diseases. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Peripheral Vascular Stents Market

The rising trend toward home-based and outpatient care is significantly boosting the demand for peripheral vascular stents. These stents are essential for effective drug delivery in patients undergoing therapies such as antibiotics, immunotherapy, nutritional support, or treatments for chronic diseases. As the focus on patient-centered care continues to grow globally, it is expected to have a favorable impact on the market for peripheral vascular stents. This shift towards more convenient and accessible healthcare options enhances the need for advanced medical solutions like stents, ultimately driving their sales and broader acceptance in the healthcare ecosystem.

Restraints in the Global Peripheral Vascular Stents Market

The sales potential of the global peripheral vascular stents market may be hindered by challenges related to the proper placement of these stents, which necessitates specialized training. Many healthcare facilities experience a shortage of qualified nurses, vascular access specialists, and trained clinicians who are adept at performing these procedures. Additionally, high staff turnover rates and restricted access to standardized certification programs further complicate the situation. These factors collectively impede the widespread adoption of peripheral vascular stents, potentially limiting their availability and usage in various healthcare settings and affecting market growth.

Market Trends of the Global Peripheral Vascular Stents Market

The Global Peripheral Vascular Stents market is witnessing a transformative shift towards home infusion therapy and long-term ambulatory care devices. Suppliers are innovating to create stents that prioritize improved durability, lower infection risk, and user-friendly maintenance, enabling their use outside of traditional hospital settings. This trend aligns with the growing preference for home-based care solutions, aimed at reducing healthcare costs and alleviating hospital congestion. As patients and healthcare providers seek more accessible and efficient treatment options, the demand for advanced peripheral vascular stents tailored for home care continues to expand, marking a significant evolution in the market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment
• Patent Analysis

Global Peripheral Vascular Stents Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Bare Metal Stents
• Drug-Eluting Stents
• Bioresorbable Stents

Global Peripheral Vascular Stents Market Size by Material Type & CAGR (2026-2033)

• Market Overview
• Stainless Steel
• Cobalt-Chromium Alloy
• Polymer-based

Global Peripheral Vascular Stents Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialized Clinics

Global Peripheral Vascular Stents Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Peripheral Artery Disease
• Coronary Artery Disease
• Other Vascular Diseases

Global Peripheral Vascular Stents Market Size & CAGR (2026-2033)

• North America (Product Type, Material Type, End User, Disease Type)
  • US
  • Canada
• Europe (Product Type, Material Type, End User, Disease Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Material Type, End User, Disease Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Material Type, End User, Disease Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Material Type, End User, Disease Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St Jude Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiovascular Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascular Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gore & Associates
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iVascular
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spectranetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medglad
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avinger
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations